How a big biotech’s start-up gamble went wrong
The Story of Money28 Juni 2023

How a big biotech’s start-up gamble went wrong

Illumina, the world’s biggest gene sequencing company, announced plans to buy cancer detection start-up Grail for $8bn while the biotech boom was in full swing. To Illumina, Grail looked like a potential gold mine. Until reality — and regulators — entered the picture. Three years and an activist investor campaign waged by Carl Icahn later, the FT’s US pharmaceutical correspondent Jamie Smyth explains the problems that have cropped up and what it means for both companies and their shareholders.


Clips from Illumina Inc / Seeking Alpha, Yahoo

- - - - - - - - - - - - - - - - - - - - - - - - - -

For further reading:

Carl Icahn takes aim at genome sequencer Illumina over Grail deal

Has Illumina taken the wrong path in its Grail quest?

Quick blood tests to spot cancer: will they help or harm patients?

- - - - - - - - - - - - - - - - - - - - - - - - - -

On Twitter, follow Jamie Smyth (@JamieSmythF) and Michela Tindera (@mtindera07)


Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Avsnitt(319)

Companies reap $22bn from Trump’s immigration crackdown

Companies reap $22bn from Trump’s immigration crackdown

Raids by the US Immigration and Customs Enforcement have made national headlines. But behind ICE’s operations, a sprawling web of private companies – from global powerhouses to niche family-run busine...

25 Feb 25min

How a private equity pioneer lost its grip on the market it invented

How a private equity pioneer lost its grip on the market it invented

Partners Group pursued an innovative approach to private equity: The firm built a business serving a market of individual investors. Now, a recent executive order from US President Donald Trump is set...

18 Feb 18min

A hedge fund’s $8bn bet on Venezuela’s Citgo

A hedge fund’s $8bn bet on Venezuela’s Citgo

When the hedge fund Elliott Management pursued the acquisition of the oil refinery business Citgo a few years ago, the deal was already a complicated one. A US court had ordered its current owner, Ven...

11 Feb 20min

How the Federal Reserve might change under Kevin Warsh

How the Federal Reserve might change under Kevin Warsh

US President Donald Trump on Friday made his pick to lead the Federal Reserve: Kevin Warsh. The former central bank governor with ties to Wall Street is seen as a mainstream pick. Still, some economis...

4 Feb 20min

Can Wells Fargo make it in investment banking?

Can Wells Fargo make it in investment banking?

For more than 170 years, Wells Fargo built a reputation as an all-American Main Street lender. Now, it is charting a new path and pushing into investment banking, something that many other banks have ...

28 Jan 19min

The rapid collapse of Saks Global

The rapid collapse of Saks Global

Saks Global, the parent company of the historic luxury department store Saks Fifth Avenue, recently filed for Chapter 11 bankruptcy protection. The move occurred a little more than a year after the co...

21 Jan 22min

Davos’ fight for relevance

Davos’ fight for relevance

Every January a collection of the world’s top business and political leaders head to the Swiss town of Davos for the annual meeting of the World Economic Forum. The event is a week of panels and netwo...

14 Jan 22min

Martin Wolf on the economy in 2026

Martin Wolf on the economy in 2026

From the artificial intelligence bubble to trade policy, Michela asks Martin Wolf, the FT's chief economics commentator, how the biggest stories of last year will affect the economy in 2026. The FT do...

7 Jan 21min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
rss-jossan-nina
rss-svart-marknad
svd-tech-brief
uppgang-och-fall
bathina-en-podcast
avanzapodden
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
rss-borsens-finest
rss-inga-dumma-fragor-om-pengar
rikatillsammans-om-privatekonomi-rikedom-i-livet
24fragor
tabberaset
borsmorgon
montrosepodden
fill-or-kill
lastbilspodden